These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33206943)

  • 1. Harnessing lymphoma epigenetics to improve therapies.
    Yang H; Green MR
    Blood; 2020 Nov; 136(21):2386-91. PubMed ID: 33206943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing lymphoma epigenetics to improve therapies.
    Yang H; Green MR
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):95-100. PubMed ID: 33275741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The follicular lymphoma epigenome regulates its microenvironment.
    Amin R; Braza MS
    J Exp Clin Cancer Res; 2022 Jan; 41(1):21. PubMed ID: 35022084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?
    Chung C
    Blood Lymphat Cancer; 2022; 12():99-106. PubMed ID: 35959380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies.
    Serganova I; Chakraborty S; Yamshon S; Isshiki Y; Bucktrout R; Melnick A; Béguelin W; Zappasodi R
    Front Cell Dev Biol; 2021; 9():805195. PubMed ID: 35071240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T follicular helper cells: a potential therapeutic target in follicular lymphoma.
    Ochando J; Braza MS
    Oncotarget; 2017 Dec; 8(67):112116-112131. PubMed ID: 29340116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
    Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
    Front Immunol; 2021; 12():683597. PubMed ID: 34335584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Programing of B-Cell Lymphoma by BCL6 and Its Genetic Deregulation.
    Yang H; Green MR
    Front Cell Dev Biol; 2019; 7():272. PubMed ID: 31788471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin modifying gene mutations in follicular lymphoma.
    Green MR
    Blood; 2018 Feb; 131(6):595-604. PubMed ID: 29158360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma.
    Meyer SN; Scuoppo C; Vlasevska S; Bal E; Holmes AB; Holloman M; Garcia-Ibanez L; Nataraj S; Duval R; Vantrimpont T; Basso K; Brooks N; Dalla-Favera R; Pasqualucci L
    Immunity; 2019 Sep; 51(3):535-547.e9. PubMed ID: 31519498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells.
    Betzler AC; Ushmorov A; Brunner C
    Front Immunol; 2023; 14():1125503. PubMed ID: 36817488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and function of CD4
    Cha Z; Gu H; Zang Y; Wang Z; Li J; Huang W; Qin A; Zhu L; Tu X; Cheng N; Song H; Qian B
    Int Immunopharmacol; 2018 Aug; 61():132-139. PubMed ID: 29870918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers.
    Andrews JM; Pyfrom SC; Schmidt JA; Koues OI; Kowalewski RA; Grams NR; Sun JJ; Berman LR; Duncavage EJ; Lee YS; Cashen AF; Oltz EM; Payton JE
    EBioMedicine; 2021 Sep; 71():103559. PubMed ID: 34461601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic determinants of diffuse large B-cell lymphoma.
    Bakhshi TJ; Georgel PT
    Blood Cancer J; 2020 Dec; 10(12):123. PubMed ID: 33277464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring
    Mansoor A; Akhter A; Hamidi M; Roshan TM; Shabani-Rad MT; Stewart D
    Anticancer Res; 2023 Nov; 43(11):4801-4807. PubMed ID: 37909960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and clinical significance of epigenetic alterations in B-cell lymphomas.
    Ennishi D
    Int J Hematol; 2022 Dec; 116(6):821-827. PubMed ID: 36208393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Analysis of Cell Crosstalk within Follicular Lymphoma Cell Niche: Towards a Definition of the FL Supportive Synapse.
    Pangault C; Amé-Thomas P; Rossille D; Dulong J; Caron G; Nonn C; Chatonnet F; Desmots F; Launay V; Lamy T; Fest T; Tarte K
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33028033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas.
    Lunning MA; Green MR
    Blood Cancer J; 2015 Oct; 5(10):e361. PubMed ID: 26473533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.